Anticoagulant activity of the enantiomers of acenocoumarol.
作者信息
Meinertz T, Kasper W, Kahl C, Jähnchen E
出版信息
Br J Clin Pharmacol. 1978 Feb;5(2):187-8. doi: 10.1111/j.1365-2125.1978.tb01622.x.
Abstract
摘要
相似文献
1
Anticoagulant activity of the enantiomers of acenocoumarol.醋硝香豆素对映体的抗凝活性。
Br J Clin Pharmacol. 1978 Feb;5(2):187-8. doi: 10.1111/j.1365-2125.1978.tb01622.x.
2
Potentiation of the acenocoumarol anticoagulant effect by acetaminophen.
Ann Pharmacother. 1999 Apr;33(4):506. doi: 10.1345/aph.18280.
3
4
Miconazole oral gel enhances acenocoumarol anticoagulant activity: a report of three cases.咪康唑口腔凝胶增强醋硝香豆素抗凝活性：三例报告
Ann Pharmacother. 1999 Feb;33(2):175-7. doi: 10.1345/aph.18011.
5
Altered pharmacokinetics of R- and S-acenocoumarol in a subject heterozygous for CYP2C9*3.CYP2C9*3基因杂合受试者中R-和S-醋硝香豆素的药代动力学改变
Clin Pharmacol Ther. 2001 Sep;70(3):292-8. doi: 10.1067/mcp.2001.117936.
6
The effect of acenocoumarol on hemorheological parameters.
Clin Hemorheol Microcirc. 2001;24(2):111-5.
7
[The effect of some anticoagulant agents on coronary blood flow].[某些抗凝剂对冠状动脉血流的影响]
Acta Physiol Pol. 1965 Nov-Dec;16(6):917-21.
8
The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol.那格列奈对醋硝香豆素药代动力学和药效学的影响。
Curr Med Res Opin. 2004 Jan;20(1):41-8. doi: 10.1185/030079903125002685.
9
The blue toe syndrome during oral anticoagulant therapy with acenocoumarol.
Thromb Haemost. 2001 Apr;85(4):743.
10
Acenocoumarol: A Review of Anticoagulant Efficacy and Safety.醋硝香豆素：抗凝疗效与安全性综述
J Assoc Physicians India. 2016 Feb;64(2):88-93.
引用本文的文献
1
Metal-mediated aminocatalysis provides mild conditions: Enantioselective Michael addition mediated by primary amino catalysts and alkali-metal ions.金属介导的氨基催化提供了温和的条件：由伯胺催化剂和碱金属离子介导的对映选择性迈克尔加成。
Beilstein J Org Chem. 2013;9:155-65. doi: 10.3762/bjoc.9.18. Epub 2013 Jan 23.
2
New oral anticoagulants: comparative pharmacology with vitamin K antagonists.新型口服抗凝药物：与维生素 K 拮抗剂的比较药理学。
Clin Pharmacokinet. 2013 Feb;52(2):69-82. doi: 10.1007/s40262-012-0030-9.
3
Pharmacogenetic aspects of coumarinic oral anticoagulant therapies.香豆素类口服抗凝治疗的药物遗传学方面
Indian J Clin Biochem. 2011 Jul;26(3):222-9. doi: 10.1007/s12291-011-0133-3. Epub 2011 May 1.
4
Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.非洲裔贝宁健康受试者中CYP2C9 *5/*8、*8/*11、*9/*11和VKORC1*2的醋硝香豆素敏感性及药代动力学特征
Eur J Drug Metab Pharmacokinet. 2012 Jun;37(2):125-32. doi: 10.1007/s13318-011-0056-7. Epub 2011 Aug 3.
5
Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.维生素K拮抗剂的比较药代动力学：华法林、苯丙香豆素和醋硝香豆素。
Clin Pharmacokinet. 2005;44(12):1227-46. doi: 10.2165/00003088-200544120-00003.
6
Clinically important drug interactions with anticoagulants. An update.与抗凝剂相关的具有临床重要意义的药物相互作用。最新进展。
Clin Pharmacokinet. 1996 Jun;30(6):416-44. doi: 10.2165/00003088-199630060-00002.
7
Pharmacokinetics of the enantiomers of acenocoumarol in man.醋硝香豆素对映体在人体中的药代动力学。
Br J Clin Pharmacol. 1981 Nov;12(5):621-9. doi: 10.1111/j.1365-2125.1981.tb01280.x.
8
Active metabolites of acenocoumarol: do they contribute to the therapeutic effect?醋硝香豆素的活性代谢产物：它们对治疗效果有贡献吗？
Br J Clin Pharmacol. 1983 Nov;16(5):491-6. doi: 10.1111/j.1365-2125.1983.tb02205.x.
9
Importance of drug enantiomers in clinical pharmacology.药物对映体在临床药理学中的重要性。
Drugs. 1985 Oct;30(4):333-54. doi: 10.2165/00003495-198530040-00003.
10
Lack of effect of cimetidine on pharmacodynamics and kinetics of single oral doses of R- and S-acenocoumarol.西咪替丁对单次口服R-和S-醋硝香豆素的药效学和药代动力学无影响。
Eur J Clin Pharmacol. 1986;30(5):619-23. doi: 10.1007/BF00542424.
本文引用的文献
1
Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.华法林。其代谢的立体化学方面以及与保泰松的相互作用。
J Clin Invest. 1974 Jun;53(6):1607-17. doi: 10.1172/JCI107711.
2
Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man.华法林对映体在人体内的药代动力学和药效学
Clin Pharmacol Ther. 1974 Apr;15(4):424-30. doi: 10.1002/cpt1974154424.
3
The plasma half lives and the pharmacological effect of the enantiomers of warfarin in rats.
Life Sci II. 1972 Apr 8;11(7):337-45. doi: 10.1016/0024-3205(72)90073-2.
4
Studies on the optical enantiomorphs of warfarin in man.
Clin Pharmacol Ther. 1974 Aug;16(2):348-54. doi: 10.1002/cpt1974162348.
5
Relationship between the kinetics of the anticoagulant effects of racemic warfarin and its individual enantiomers in man.消旋华法林及其单个对映体在人体中的抗凝作用动力学之间的关系。
Res Commun Chem Pathol Pharmacol. 1974 Feb;7(2):359-65.
6
Pharmacokinetics of the warfarin enantiomers in rats.
J Pharmacokinet Biopharm. 1974 Jun;2(3):239-55. doi: 10.1007/BF01059764.
7
The plasma half-lives of the enantiomers of warfarin in warfarin-resistant and warfarin-susceptible rats.华法林抗性和华法林敏感大鼠中华法林对映体的血浆半衰期。
J Pharm Pharmacol. 1972 Aug;24(8):661-2. doi: 10.1111/j.2042-7158.1972.tb09083.x.
8
Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man.
J Pharm Pharmacol. 1973 Jun;25(6):458-65. doi: 10.1111/j.2042-7158.1973.tb09133.x.
9
The enantiomers of phenprocoumon: pharmacodynamic and pharmacokinetic studies.苯丙香豆素的对映体：药效学和药代动力学研究。
Clin Pharmacol Ther. 1976 Sep;20(3):342-9. doi: 10.1002/cpt1976203342.
10
Biotransformation and pharmacokinetics of acenocoumarol (Sintrom) in man.
Eur J Clin Pharmacol. 1977;11(5):367-75. doi: 10.1007/BF00566534.
Zotero 插件